Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.612
-0.018 (-2.90%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Oragenics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-9.84-10.57-20.66-14.29-15.71
Upgrade
Depreciation & Amortization
--0.030.040.04
Upgrade
Other Amortization
0.77----
Upgrade
Loss (Gain) From Sale of Assets
--0.03-0.01-
Upgrade
Asset Writedown & Restructuring Costs
--10.27--
Upgrade
Stock-Based Compensation
0.680.521.020.741.69
Upgrade
Change in Accounts Payable
0.2-0.120.030.180.01
Upgrade
Change in Other Net Operating Assets
-1.061.571.99-1.890.5
Upgrade
Operating Cash Flow
-9.25-8.6-7.29-15.23-13.47
Upgrade
Capital Expenditures
----0.13-0.04
Upgrade
Sale of Property, Plant & Equipment
--0.060.01-
Upgrade
Other Investing Activities
---1--
Upgrade
Investing Cash Flow
---0.94-0.12-0.04
Upgrade
Short-Term Debt Issued
2.46----
Upgrade
Total Debt Issued
2.46----
Upgrade
Short-Term Debt Repaid
-3.33-0.69-0.57-0.56-0.52
Upgrade
Total Debt Repaid
-3.33-0.69-0.57-0.56-0.52
Upgrade
Net Debt Issued (Repaid)
-0.87-0.69-0.57-0.56-0.52
Upgrade
Issuance of Common Stock
2.636.670.850.0729.3
Upgrade
Financing Cash Flow
16.785.980.28-0.4923.14
Upgrade
Net Cash Flow
7.53-2.62-7.94-15.849.63
Upgrade
Free Cash Flow
-9.25-8.6-7.29-15.36-13.51
Upgrade
Free Cash Flow Margin
---19363.34%-11675.70%-15535.76%
Upgrade
Free Cash Flow Per Share
-4.29-38.95-97.23-229.30-208.66
Upgrade
Cash Interest Paid
0.020.030.030.010.02
Upgrade
Levered Free Cash Flow
-5.75-6.45-9.23-10.59-8.27
Upgrade
Unlevered Free Cash Flow
-6.03-6.43-9.21-10.58-8.26
Upgrade
Change in Working Capital
-0.861.452.02-1.720.51
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.